Skip to main content
. Author manuscript; available in PMC: 2014 Mar 12.
Published in final edited form as: Clin Pharmacol Ther. 2012 Oct 3;92(5):575–583. doi: 10.1038/clpt.2012.137

Figure 4.

Figure 4

Visual predictive check for the final atazanavir model stratified for different CYP3A5 genotypes: homozygote *3*3 shown in the left panel and heterozygote *1*3 and homozygote *1*1 shown in the right panel. Red solid line indicates observed data median, red dotted lines are 95% observed percentiles, grey shaded area is the simulated median with uncertainty and dark grey shaded areas are simulated 95% percentiles with uncertainty.